Skip to main content
Premium Trial:

Request an Annual Quote

Cellectis, Bayer Developing Meganuclease-Based Products for Plants

NEW YORK (GenomeWeb News) – Cellectis plant sciences and Bayer CropScience are collaborating to develop commercial products for the agricultural seed markets, the Paris-based plant genome engineering and subsidiary of Cellectis said today.

The collaboration centers on the use of meganucleases in plants, and the products being developed will use new breeding techniques such as gene stacking and targeted mutagenesis. Cellectis and Bayer have collaborated since 2006 in plant genome engineering to evaluate the "value for commercial applications" of the meganuclease technology, and following the successful completion of that assessment, the firms decided to extend their partnership into a research and commercial agreement, Cellectis said.

The new agreement calls for Cellectis to provide Bayer with custom-designed meganucleases for plant genomes to introduce targeted modifications to selected genes and genomes.

Financial and other terms were not disclosed.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.